SHANGHAI, 9. März 2026 /PRNewswire/ -- Das Jiahui International Cancer Center (JICC) hat einen US-Patienten mit fortgeschrittenem nicht-kleinzelligem Lungenkrebs (NSCLC) und Parkinson-Krankheit mit Ivonescimab stabilisiert, einer neuartigen Immuntherapie, die derzeit nur in China...
Hence then, the article about us patient mit fortgeschrittenem lungenkrebs durch neuartige immuntherapie behandlung in china stabilisiert was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( US-Patient mit fortgeschrittenem Lungenkrebs durch neuartige Immuntherapie-Behandlung in China stabilisiert )
Also on site :
- Who is Iran’s new supreme leader Mojtaba Khamenei? Son of Ayatollah Ali Khamenei to take over father’s role
- Egypt Proposes Forming Joint Arab Defense Force Amid Regional Tensions
- "Al-Qassam" Spokesperson: We Bless Fighters of Lebanese Resistance for Confronting Zionist Aggression, Striking Depth of Entity